Status:
TERMINATED
Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer
Lead Sponsor:
University of Louisville
Collaborating Sponsors:
James Graham Brown Cancer Center
Sanofi
Conditions:
Carcinoma, Non-Small Cell Lung
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine the most suitable dose of Oxaliplatin that can be safely given in combination with a low fixed dose of Capecitabine and a limited volume of radiation in patie...
Detailed Description
The purpose of this study is to determine the maximum tolerated dose (MTD) and the dose limiting toxicity (DLT) of Oxaliplatin in combination with Capecitabine and radiation in subjects with non-small...
Eligibility Criteria
Inclusion
- histologically proven non-small cell lung cancer
- inoperable Stage III A or B NSCLC
- must have measurable disease by RECIST criteria
- no more than one prior chemotherapy for advanced disease
- ECOG Performance Status of 0, 1, or 2
- must be able to swallow pills or have a working gastric feeding tube and no evidence of malabsorption
- negative serum beta-HCG test and under active contraception (for females of childbearing potential)
- no known allergies to any of the study drugs
- willingness to sign an informed consent
Exclusion
- women who are pregnant or breastfeeding
- ANC of less than 1500/mm3
- platelet count of less than 100,000/mm3
- estimated creatinine clearance of less than 50 cc/min (as measured by the Cockcroft-Gault equation)
- bilirubin of less than 2mg/dl
- SGPT of greater than 2x nl
- peripheral neuropathy of Grade 2 or higher
- more than one previous chemotherapy and previous radiation therapy to the chest
- a history of CHF/MI or other significant cardiac history within the last six months
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00268151
Start Date
February 1 2005
Last Update
March 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
James Graham Brown Cancer Center
Louisville, Kentucky, United States, 40202